shortage of refined glycerine in the market, resulting in a significant reduction in production. In addition, the domestic market has limited availability of refined glycerine as raw materials from biodiesel
or 49.49%, the main factors from the selling price are increase 64.96% as compared to the same period of last year, due to the epidemic of the COVID-19 around the world, there is a shortage of refined
situation has been considered a major factor causing the global economic slowdown and affecting the society as a whole. It also caused a global semiconductor shortage crisis, which is another factor that
1,015.5 816.4 80.4 Deficit from business combination under common control (22.9) (22.9) - - Total equity 10,793.0 5,571.6 5,221.4 93.7 31 December Statement of Financial Position Change 3. Analysis of
Deficit from business combination under common control (22.9) (22.9) - - Total equity 11,386.6 10,793.0 593.6 5.5 Statement of Financial Position Change Analysis of Financial Position 10 Assets Total assets
Total liabilities 7,743.2 8,315.1 (571.9) (6.9) Issued and paid-up share capital 4,579.0 4,579.0 - - Retained earnings - unappropriated 1,585.5 1,015.5 570.0 56.1 Deficit (22.9) (22.9) - - Total equity
1,015.5 816.4 80.4 Deficit from business combination under common control (22.9) (22.9) - - Total equity 10,793.0 5,571.6 5,221.4 93.7 31 December Statement of Financial Position Change 3. Analysis of
50,000,000 50,000,000 Issued and paid-up share capital 27,500,000 50,000,000 50,000,000 Deficit (25,996,806) (35,050,267) (27,534,328) Total equity 1,503,194 14,949,733 22,465,672 Total liabilities and equity
capital 50,000,000 50,000,000 50,000,000 Issued and paid-up share capital 27,500,000 50,000,000 50,000,000 Deficit (25,996,806) (35,050,267) (27,534,328) Total equity 1,503,194 14,949,733 22,465,672 Total
Issued and paid-up share capital 27,500,000 50,000,000 50,000,000 Deficit (25,996,806) (35,050,267) (27,534,328) Total equity 1,503,194 14,949,733 22,465,672 Total liabilities and equity 4,264,088